https://www.contemporarypediatrics.com/view/fda-accepts-slba-for-altuviiio-in-children-with-hemophilia-a
0
0
9/12/23 at 6:57pm
Organization
Contemporarypediatrics.com
41 words
0
Comments
A supplemental biologics license application for ALTUVIIIO (Antihemophilic factor; Sanofi) has been accepted by the FDA for use in patients aged 12 years and older with severe hemophilia A.
You are the first to view
Create an account
or login to join the discussion